Olivier Corbeil has been a clinical pharmacist at the First-Episode Psychosis Program of the Quebec Mental Health University Institute since 2019. He is also completing his Ph.D. in Pharmaceutical Sciences at Université Laval’s Faculty of Pharmacy, Canada, where his research centers on early intervention for psychotic disorders and their comorbidities, including behavioral addictions and attention-deficit/hyperactivity disorder (ADHD). His work focuses on optimizing the safety and efficacy of pharmacological treatments through naturalistic cohort studies and large-scale population-based registry analyses. As a postdoctoral fellow in the SCIENCES Lab, Olivier leads a research program on ADHD in individuals with psychotic disorders, addressing critical gaps in treatment. His work integrates evidence from multiple interconnected studies to develop tailored guidelines that enhance clinical practice and improve patient recovery outcomes.

Lab Memberships: SCIENCES Lab